Home/Pipeline/RORγt Inhibitor (SAR441169)

RORγt Inhibitor (SAR441169)

Autoimmune Diseases (Immunology)

Phase I/IIActive (Partnered)

Key Facts

Indication
Autoimmune Diseases (Immunology)
Phase
Phase I/II
Status
Active (Partnered)
Company

About Lead Pharma

Lead Pharma is a private, clinical-stage biotech leveraging a robust, integrated discovery engine to develop small-molecule drugs for oncology and immunology. The company has a proven track record of advancing programs to clinical stages, evidenced by its partnered RORγt inhibitor (SAR441169 with Sanofi) and an internal ERRα program. With a focus on difficult-to-drug targets, Lead Pharma's business model centers on internal pipeline development and strategic partnerships to bring life-changing treatments to patients.

View full company profile

Therapeutic Areas